血液凝固的ex vivo评估在内皮糖核激素启发的表面使用血栓凝结术
Yanyi Zang1,2, Jessi R Vlcek1, Jamie Cuchiaro3
1School of Biomedical Engineering, Colorado State University, Fort Collins, CO USA.
In vitro models
|January 28, 2025
概括
这项研究开发了一种灵感来自内皮糖核的仿生表面,以减少血液凝结. 经过修改的表面,结合纳米拓和氧化释放,有效地减缓或抑制了人体全血中的凝块形成.
科学领域:
- 生物材料科学 生物材料科学
- 表面化学 表面化学
- 血液静止研究 血液静止研究
背景情况:
- 当前接触血液的材料面临着在没有不良临床影响的情况下预防凝血的挑战.
- 开发先进的生物材料对于改善医疗器械性能和患者的治疗结果至关重要.
研究的目的:
- 为了评估内皮糖核糖体启发生物模拟表面在减少人体全血凝固的有效性.
- 评估浸出多糖和化学修饰对开发表面抗凝固特性的影响.
主要方法:
- 使用血栓形成显微镜 (TEG) 来测量全血凝块形成的参数.
- 使用的折射率和减弱的总反射率-里埃变换红外光谱学 (ATR-FTIR) 来检测液化多糖和分析化学变化.
主要成果:
- 含有氨酸的表面显示出减缓或抑制血块形成的能力.
- 在化和NO释放后,在NO释放表面的化溶液中检测到多糖.
- 硫化基和肝素的化学结构被t-丁酸盐改变.
结论:
- 这项研究首次评估了使用临床相关的凝血参数对内皮葡萄糖灵感表面的评估.
- 这项研究突出了这些修饰表面在抑制血块形成方面的潜力,为抗凝剂材料的开发提供了有前途的方向.
相关概念视频
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...